The Immune-Modulator Pidotimod Affects the Metabolic Profile of Exhaled Breath Condensate in Bronchiectatic Patients: A Metabolomics Pilot Study

The Immune-Modulator Pidotimod Affects the Metabolic Profile of Exhaled Breath Condensate in Bronchiectatic Patients: A Metabolomics Pilot Study

Introduction: Pidotimod, a synthetic dipeptide molecule with biological and immunological activities, is used to reduce the number of exacerbations or pneumonitis in patients with inflammatory diseases.In the present study, we investigated whether Pidotimod modifies the metabolomic pathways measured...

Full description

Bibliographic Details
Main Authors: Maria D’Amato, Debora Paris, Antonio Molino, Paola Cuomo, Andrea Fulgione, Nunzia Sorrentino, Letizia Palomba, Mauro Maniscalco, Andrea Motta
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-10-01
Series:Frontiers in Pharmacology
Subjects:
biomarkers
bronchiectasis
disability
exhaled
metabolomics
NMR
Online Access:https://www.frontiersin.org/article/10.3389/fphar.2019.01115/full

Internet

https://www.frontiersin.org/article/10.3389/fphar.2019.01115/full

Similar Items